HIGHEST PERFORMANCES HOLDING (HPH)

US69373Y1091 - ADR

0.3564  +0.02 (+4.7%)

Fundamental Rating

3

Overall HPH gets a fundamental rating of 3 out of 10. We evaluated HPH against 219 industry peers in the Capital Markets industry. The financial health of HPH is average, but there are quite some concerns on its profitability. HPH is valued expensive and it does not seem to be growing.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

HPH had negative earnings in the past year.
HPH had a positive operating cash flow in the past year.
In the past 5 years HPH always reported negative net income.
In the past 5 years HPH reported 4 times negative operating cash flow.

1.2 Ratios

HPH has a Return On Assets of -7.57%. This is amonst the worse of the industry: HPH underperforms 92.06% of its industry peers.
HPH's Return On Equity of -24.33% is on the low side compared to the rest of the industry. HPH is outperformed by 86.45% of its industry peers.
Industry RankSector Rank
ROA -7.57%
ROE -24.33%
ROIC N/A
ROA(3y)-12.12%
ROA(5y)-10.77%
ROE(3y)-21.75%
ROE(5y)-17.73%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

HPH's Gross Margin of 40.70% is on the low side compared to the rest of the industry. HPH is outperformed by 67.76% of its industry peers.
In the last couple of years the Gross Margin of HPH has declined.
The Profit Margin and Operating Margin are not available for HPH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.86%
GM growth 5Y-14.09%

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for HPH remains at a similar level compared to 1 year ago.
Compared to 5 years ago, HPH has more shares outstanding
The debt/assets ratio for HPH is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.70, we must say that HPH is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of HPH (0.70) is comparable to the rest of the industry.
The Debt to FCF ratio of HPH is 1.84, which is an excellent value as it means it would take HPH, only 1.84 years of fcf income to pay off all of its debts.
HPH's Debt to FCF ratio of 1.84 is amongst the best of the industry. HPH outperforms 84.11% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that HPH is not too dependend on debt financing.
HPH's Debt to Equity ratio of 0.07 is amongst the best of the industry. HPH outperforms 82.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.84
Altman-Z 0.7
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 2.80 indicates that HPH has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.80, HPH is doing good in the industry, outperforming 76.64% of the companies in the same industry.
A Quick Ratio of 2.80 indicates that HPH has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.80, HPH is in the better half of the industry, outperforming 76.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.8
Quick Ratio 2.8

More info and screens

3

3. Growth

3.1 Past

HPH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -230.26%.
Looking at the last year, HPH shows a very strong growth in Revenue. The Revenue has grown by 967.12%.
HPH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.29% yearly.
EPS 1Y (TTM)-230.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-831.37%
Revenue 1Y (TTM)967.12%
Revenue growth 3Y83.7%
Revenue growth 5Y42.29%
Sales Q2Q%2476.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HPH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, HPH is valued a bit cheaper than 65.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.09
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

HPH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HIGHEST PERFORMANCES HOLDING

NASDAQ:HPH (1/3/2025, 8:00:01 PM)

0.3564

+0.02 (+4.7%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)03-04 2024-03-04/amc
Earnings (Next)N/A N/A
Inst Owners0.01%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap88.52M
AnalystsN/A
Price TargetN/A
Short Float %0%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.53
P/FCF 12.09
P/OCF 11.19
P/B 0.49
P/tB 0.96
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.03
FCFY8.27%
OCF(TTM)0.03
OCFY8.94%
SpS0.67
BVpS0.73
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.57%
ROE -24.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.7%
FCFM 4.38%
ROA(3y)-12.12%
ROA(5y)-10.77%
ROE(3y)-21.75%
ROE(5y)-17.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.86%
GM growth 5Y-14.09%
F-Score4
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.84
Debt/EBITDA N/A
Cap/Depr 7.27%
Cap/Sales 0.35%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.8
Quick Ratio 2.8
Altman-Z 0.7
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)45.7%
Cap/Depr(5y)105.98%
Cap/Sales(3y)1.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-230.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-831.37%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)967.12%
Revenue growth 3Y83.7%
Revenue growth 5Y42.29%
Sales Q2Q%2476.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y296.13%
FCF growth 3YN/A
FCF growth 5Y-10.53%
OCF growth 1Y327.63%
OCF growth 3YN/A
OCF growth 5Y-10.05%